Variable clinical phenotypes of alpha‐methylacyl‐ CoA racemase deficiency: Report of four cases and review of the literature
JIMD Reports · 2024-09 · 65 (5) · 305-312
DOI: 10.1002/jmd2.12437 ↗Kurz gefasst
Fachartikel in der Zeitschrift JIMD Reports, online erschienen am 11.07.2024. Verfasst von Arzu Selamioğlu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Bağcılar Training and Research Hospital Division of Pediatric Metabolic Diseases Istanbul Turkey. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Alpha‐methylacyl‐ CoA ‐racemase ( AMACR ) deficiency ( MIM #604489) is a peroxisomal disorder resulting in the accumulation of pristanic acid, dihydroxycholestanoic acid ( DHCA ), and trihydroxycholestanoic acid ( THCA ), with variable clinical features and age of onset from infancy to late adulthood. The purpose of this report is to define clinical variations and follow‐up data in AMACR deficiency emphasizing treatment with a review of cases reported in the literature. Here, four patients, from two families, diagnosed with AMACR deficiency and showing phenotypic heterogeneity are presented. A 10‐month‐old‐female presented with coagulopathy, hepatic dysfunction, and elevated pristanic acid, DHCA, and THCA levels. Genetic testing confirmed a homozygous variant c. 596G >A in the AMACR gene. Her brother who had macrovesicular hepatosteatosis and elevated pristanic acid levels was diagnosed with family screening. The third patient presented with rhabdomyolysis following a strenuous exercise without any other complaint. Homozygous novel c. 1006G >A variant was found on the AMACR gene. His asymptomatic sister carrying the same variant also had elevated pristanic acid levels. They had normal neuropsychologic evaluation. Dietary treatment with low phytanic and pristanic acid content was recommended to the patients but all showed poor compliance. The sibling pairs were followed for periods of 11 and 7 years, respectively. AMACR deficiency is usually described as an adult‐onset disorder with neuropsychological problems. The characterization of natural history and new clinical phenotypes may support earlier diagnosis and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bağcılar Training and Research Hospital Division of Pediatric Metabolic Diseases Istanbul Turkey.
- Department of Rare Diseases, Institute of Graduate Studies in Health Sciences Istanbul University Istanbul Turkey.
- Division of Pediatric Nutrition and Metabolism Istanbul University Faculty of Medicine Istanbul Turkey.
- Inborn Errors of Metabolism, Genetics and Genomic Medicine UCL Great Ormond Street Institute of Child Health London UK.
- Department of Neurology Istanbul University Faculty of Medicine Istanbul Turkey.
- Division of Medical Genetics, Department of Pediatric Basic Sciences, Institute of Child Health Istanbul University Istanbul Turkey.
ORCID-Profile: Gülden Gökçay
Zitieren
APA
Selamioğlu, A., Balcı, M. C., Karaca, M., Khalil, Y., Hirachan, R., Durmuş Tekçe, H., Parman, Y. G., Gedikbaşı, A., Demirkol, M., Clayton, P., & Gökçay, G. (2024). Variable clinical phenotypes of alpha‐methylacyl‐ CoA racemase deficiency: Report of four cases and review of the literature. JIMD Reports, 65(5), 305-312. https://doi.org/10.1002/jmd2.12437
Vancouver
Selamioğlu A, Balcı MC, Karaca M, Khalil Y, Hirachan R, Durmuş Tekçe H, et al. Variable clinical phenotypes of alpha‐methylacyl‐ CoA racemase deficiency: Report of four cases and review of the literature. JIMD Reports. 2024;65(5):305-312. doi:10.1002/jmd2.12437
BibTeX
@article{Selamiolu2024,
author = {Selamioğlu, Arzu and Balcı, Mehmet Cihan and Karaca, Meryem and Khalil, Youssef and Hirachan, Rohit and Durmuş Tekçe, Hacer and Parman, Yeşim Gülşen and Gedikbaşı, Asuman and Demirkol, Mübeccel and Clayton, Peter and Gökçay, Gülden},
title = {Variable clinical phenotypes of alpha‐methylacyl‐ CoA racemase deficiency: Report of four cases and review of the literature},
journal = {JIMD Reports},
year = {2024},
volume = {65},
number = {5},
pages = {305--312},
doi = {10.1002/jmd2.12437}
}
EUVIMED